Our members
The International Alliance for Cancer Early Detection (ACED) brings together seven leading institutions working collaboratively to advance cancer early detection.
Who we are
Since the Alliance was established in 2019, our membership has evolved to include multidisciplinary research centres spanning the UK, US and Europe.
Each member centre contributes complementary expertise, infrastructure and research strengths, creating opportunities for collaboration that would not be possible through a single institution alone.
Current members
Cancer Research UK
The world’s leading cancer charity dedicated to saving and improving lives through research. Early detection research is a core strategic priority.
Dana-Farber Cancer Institute
A leading National Cancer Institute-designated Comprehensive Cancer Center, advancing research from basic science to population health studies.
The University of Manchester
A global leader in early detection, combining clinical excellence with community research to improve outcomes in hereditary cancers, immunology and health inequalities.
German Cancer Research Center (DKFZ)
Germany’s largest biomedical research institute with research spanning the translational continuum, including strategic focus on cancer prevention.
University College London (UCL)
Renowned for its expertise in imaging science and data-driven research, integrating clinical cohorts, biomarkers and computational infrastructure to advance early detection approaches.
Knight Cancer Institute at OHSU
Home to The Cancer Early Detection Advanced Research Center (CEDAR) and internationally recognised for single-cell analysis, biofabrication and proteomics.
University of Cambridge
A world-leading centre for early cancer detection, bringing together expert researchers, unique longitudinal clinical cohorts and industry partnerships to drive earlier prediction and intervention.
Past members
Canary Center at Stanford
A founding member of ACED, Canary Center is a world-class research facility based at the Stanford School of Medicine dedicated to precision treatment and early detection.
You may also be interested in
Our research portfolio
Explore our four research themes, meet the research theme leads and learn what our member centre teams are working on.
Partner with us
We’re looking for new partners to expand our reach in early detection. We’re interested in working with research institutions and universities, biotech and pharmaceutical companies, funders, philanthropists and impact investors.
Latest news
Stay up to date with the latest developments across the Alliance, including publications, research highlights, events and training opportunities.